These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24180544)

  • 1. Deactivation of implantable cardioverter-defibrillators at end of life.
    Pettit SJ; Jackson CE; Gardner RS
    Future Cardiol; 2013 Nov; 9(6):885-96. PubMed ID: 24180544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICD deactivation: review of literature and clinical recommendations.
    Thanavaro JL
    Clin Nurs Res; 2013 Feb; 22(1):36-50. PubMed ID: 22645402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
    Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
    Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues.
    Fluur C; Bolse K; Strömberg A; Thylén I
    Heart Lung; 2013; 42(3):202-7. PubMed ID: 23273655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
    Russo JE
    Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defibrillator patients should not be denied a peaceful death.
    Westerdahl AK; Sutton R; Frykman V
    Int J Cardiol; 2015 Mar; 182():440-6. PubMed ID: 25597981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly.
    Wright GA; Klein GJ; Gula LJ
    Curr Opin Cardiol; 2013 Jan; 28(1):43-9. PubMed ID: 23128499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardiac defibrillators and end-of-life care--time for reflection, deliberation and debate?
    Sheehan M; Newton PJ; Stobie P; Davidson PM
    Aust Crit Care; 2011 Nov; 24(4):279-84. PubMed ID: 21676627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.
    Marinskis G; van Erven L;
    Europace; 2010 Aug; 12(8):1176-7. PubMed ID: 20663788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy.
    Sherazi S; McNitt S; Aktas MK; Polonsky B; Shah AH; Moss AJ; Daubert JP; Zareba W
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1273-9. PubMed ID: 23731284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Documented consent process for implantable cardioverter-defibrillators and implications for end-of-life care in older adults.
    Niewald A; Broxterman J; Rosell T; Rigler S
    J Med Ethics; 2013 Feb; 39(2):94-7. PubMed ID: 23139392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deactivation of Implantable Cardioverter Defibrillator in Patients With Terminal Diagnoses.
    Trussler A; Alexander B; Campbell D; Alhammad N; Enriquez A; Chacko S; Garrett T; Simpson C; Redfearn D; Abdollah H; Herx L; Baranchuk A
    Am J Cardiol; 2019 Oct; 124(7):1064-1068. PubMed ID: 31353003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' perspective on deactivation of the implantable cardioverter-defibrillator near the end of life.
    Pedersen SS; Chaitsing R; Szili-Torok T; Jordaens L; Theuns DA
    Am J Cardiol; 2013 May; 111(10):1443-7. PubMed ID: 23490027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Implantable cardioverter-defibrillator deactivation at the end of life: ethical, clinical and communication issues].
    Romanò M; Piga MA; Bertona R; Negro R; Ruggeri C; Zorzoli F; Villani R
    G Ital Cardiol (Rome); 2017 Feb; 18(2):139-149. PubMed ID: 28398367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planning for Deactivation of Implantable Cardioverter Defibrillators at the End of Life in Patients With Heart Failure.
    Brady DR
    Crit Care Nurse; 2016 Dec; 36(6):24-31. PubMed ID: 27908943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure?
    Waterhouse E; Ahmad F
    Curr Opin Support Palliat Care; 2011 Dec; 5(4):307-11. PubMed ID: 22025091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICDs in end-stage heart failure.
    Pettit SJ; Browne S; Hogg KJ; Connelly DT; Gardner RS; May CR; Macleod U; Mair FS
    BMJ Support Palliat Care; 2012 Jun; 2(2):94-7. PubMed ID: 24654046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. End-of-life decisions in ICD patients with malignant tumors.
    Kobza R; Erne P
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):845-9. PubMed ID: 17584265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillator recipient attitudes towards device deactivation: how much do patients want to know?
    Raphael CE; Koa-Wing M; Stain N; Wright I; Francis DP; Kanagaratnam P
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1628-33. PubMed ID: 21955046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.